Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase

References

Page 1

	Year	Citations
High density lipoprotein as a protective factor against coronary heart disease Tavia Gordon, William P. Castelli, Marthana C. Hjortland, The American Journal of Medicine High DensityProtective FactorCardiovascular DiseaseAtherosclerosisHyperlipidemia	1977	5.1K
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis David S. Celermajer, Keld E. Sørensen, Vanda M. Gooch, The Lancet Vascular DiseaseCardiovascular EpidemiologyCardiovascular DiseaseMicrovascular DysfunctionEndothelial Dysfunction	1992	4.7K
Effects of Torcetrapib in Patients at High Risk for Coronary Events Philip J. Barter, Mark J. Caulfield, Mats Eriksson, New England Journal of Medicine	2007	3.1K
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome Gregory G. Schwartz, Anders Olsson, Markus Abt, New England Journal of Medicine	2012	2K
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis Amit Khera, Marina Cuchel, Margarita de la Llera-Moya, New England Journal of Medicine	2011	1.9K
HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events Philip J. Barter, Antonio M. Gotto, John C. LaRosa, New England Journal of Medicine	2007	1.6K
Cardiovascular disease in Europe: epidemiological update Melanie Nichols, Nick Townsend, Peter Scarborough, European Heart Journal HypertensionHeart FailurePreventive CardiologyCoronary Artery DiseaseCurrent Burden	2013	1.3K
Cardiovascular disease in Europe 2014: epidemiological update Melanie Nichols, Nick Townsend, Peter Scarborough, European Heart Journal	2014	1.3K
Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction David S. Celermajer, Keld E. Sørensen, Catherine Bull, Journal of the American College of Cardiology Vascular DiseaseCardiovascular DiseasePhysiologyEndothelial DysfunctionCardiology	1994	1.2K
Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease Christopher P. Cannon, Sukrut Shah, Hayes M. Dansky, New England Journal of Medicine	2010	746

Page 1